|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
2001-5-4
|
|
pubmed:abstractText |
99mTc-methoxyisobutylisonitrile (99mTc-MIBI) has been suggested as a tracer for the scintigraphic detection of multidrug resistance (MDR). The aim of this study was to compare MDR characteristics in vitro and in vivo by immunohistochemic and functional uptake assays in established tumor cell lines cultured and grown in severe combined immunodeficient (SCID) mice.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0161-5505
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
42
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
646-54
|
|
pubmed:dateRevised |
2004-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:11337555-Animals,
pubmed-meshheading:11337555-Colonic Neoplasms,
pubmed-meshheading:11337555-Drug Resistance, Multiple,
pubmed-meshheading:11337555-Fluorodeoxyglucose F18,
pubmed-meshheading:11337555-Humans,
pubmed-meshheading:11337555-Immunohistochemistry,
pubmed-meshheading:11337555-Male,
pubmed-meshheading:11337555-Mice,
pubmed-meshheading:11337555-Mice, Inbred BALB C,
pubmed-meshheading:11337555-Mice, SCID,
pubmed-meshheading:11337555-Neoplasm Transplantation,
pubmed-meshheading:11337555-P-Glycoprotein,
pubmed-meshheading:11337555-Radiopharmaceuticals,
pubmed-meshheading:11337555-Rhodamine 123,
pubmed-meshheading:11337555-Technetium Tc 99m Sestamibi,
pubmed-meshheading:11337555-Tomography, Emission-Computed,
pubmed-meshheading:11337555-Tumor Cells, Cultured
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
In vitro and in vivo tracer characteristics of an established multidrug-resistant human colon cancer cell line.
|
|
pubmed:affiliation |
Departments of Neuroanatomy and Nuclear Medicine, University Hospital Eppendorf, Hamburg, Germany.
|
|
pubmed:publicationType |
Journal Article
|
